Author details

Full Name

Evan F Lind

Affiliation

Oregon Health & Science University

ORCID

Career Start Year

1999

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36681742	BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8<sup>+</sup> T cells.	Leukemia	2023
37781631	Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.	bioRxiv	2023
37199721	Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.	Clin Cancer Res	2023
35868306	Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.	Cancer Cell	2022
32203139	Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.	Leukemia	2021
32898857	Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.	Blood	2021
32513686	Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.	Proc Natl Acad Sci U S A	2020
30651561	Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.	Nat Commun	2019
31648326	Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway.	Blood Adv	2019
30425048	CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.	Blood	2019
29175391	Integrated functional and mass spectrometry-based flow cytometric phenotyping to describe the immune microenvironment in acute myeloid leukemia.	J Immunol Methods	2018
30067970	Timed Regulation of 3BP2 Induction Is Critical for Sustaining CD8<sup>+</sup> T Cell Expansion and Differentiation.	Cell Rep	2018
29951373	Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.	Front Oncol	2018
27424808	Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.	Cancer Cell	2016
25882048	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.	Cell Death Differ	2015
26447227	miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1.	J Immunol	2015
24571026	Mir-155, a central modulator of T-cell responses.	Eur J Immunol	2014
23275599	Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges.	J Immunol	2013
21765460	The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.	Oncogene	2012
22763442	IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.	Nature	2012
22529912	Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells.	PLoS One	2012
20133759	HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.	Proc Natl Acad Sci U S A	2010
19995955	Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo.	J Exp Med	2009
18566401	Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens.	J Immunol	2008
17360936	The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.	Blood	2007
17374402	Strategies for selective priming of memory B cells.	Immunol Lett	2007
16921386	Mast cells are essential intermediaries in regulatory T-cell tolerance.	Nature	2006
17114443	Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor.	J Immunol	2006
15032580	CD40/CD154 interactions at the interface of tolerance and immunity.	Annu Rev Immunol	2004
12049718	Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo.	Immunity	2002
11967542	The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.	Nat Immunol	2002
11457887	Mapping precursor movement through the postnatal thymus reveals specific microenvironments supporting defined stages of early lymphoid development.	J Exp Med	2001
10421778	A dominant-negative mutant of c-Jun inhibits cell cycle progression during the transition of CD4(-)CD8(-) to CD4(+)CD8(+) thymocytes.	Int Immunol	1999
10228014	Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.	J Immunol	1999

1 - 34 of 34

Virginia Camacho

Boston Children's Hospital, Harvard Medical School

Career Start Year 2014

Number of shared co-authors 0

Ang Cui

Massachusetts Institute of Technology

Career Start Year 2013

Number of shared co-authors 0

Dipti Vijayan

QIMR Berghofer Medical Research Institute

Career Start Year 2011

Number of shared co-authors 0

Huiyuan Zhang

Texas Children's Cancer Center

Career Start Year 2010

Number of shared co-authors 2

Jianying Zhang

City of Hope National Medical Center

Career Start Year 2009

Number of shared co-authors 1

Benjamin G Vincent

UNC School of Medicine, The University of North Carolina at Chapel Hill

Career Start Year 2008

Number of shared co-authors 1

Camille Lobry

INSERM U1170, Universite Paris Saclay

Career Start Year 2007

Number of shared co-authors 1

Sasan Zandi

University of Toronto

Career Start Year 2006

Number of shared co-authors 4

Tori N Yamamoto

National Cancer Institute

Career Start Year 2005

Number of shared co-authors 0

Ansuman T Satpathy

Stanford University

Career Start Year 2005

Number of shared co-authors 1

Ido Amit

Weizmann Institute of Science

Career Start Year 2004

Number of shared co-authors 3

Robert S Welner

University of Alabama at Birmingham

Career Start Year 2002

Number of shared co-authors 1

Kimberly R Jordan

University of Colorado Anschutz Medical Campus

Career Start Year 2002

Number of shared co-authors 0

Martin Prlic

Fred Hutchinson Cancer Research Center

Career Start Year 2001

Number of shared co-authors 0

Miriam Merad

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Career Start Year 2000

Number of shared co-authors 2

John T Chang

University of California San Diego

Career Start Year 1999

Number of shared co-authors 1

Sunil K Joshi

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 1998

Number of shared co-authors 20

Peter T Sage

Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School

Career Start Year 1998

Number of shared co-authors 1

Angela G Fleischman

University of California Irvine

Career Start Year 1998

Number of shared co-authors 20

Seunghee Kim-Schulze

Icahn School of Medicine at Mount Sinai

Career Start Year 1996

Number of shared co-authors 1

Andrew D Wells

Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia

Career Start Year 1996

Number of shared co-authors 0

Cynthia Perez

Loyola University Chicago

Career Start Year 1995

Number of shared co-authors 0

Alexander Tarakhovsky

The Rockefeller University

Career Start Year 1994

Number of shared co-authors 0

Jonathan S Serody

The University of North Carolina School of Medicine

Career Start Year 1991

Number of shared co-authors 1

Nir Hacohen

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 1

Geoffrey Neale

St. Jude Children's Research Hospital

Career Start Year 1989

Number of shared co-authors 2

Frances T Hakim

National Cancer Institute

Career Start Year 1984

Number of shared co-authors 0

Louis M Staudt

National Cancer Institute, National Institutes of Health

Career Start Year 1983

Number of shared co-authors 4

Carl H June

University of Pennsylvania Department of Pathology & Laboratory Medicine

Career Start Year 1978

Number of shared co-authors 1

Ronald E Gress

National Cancer Institute, National Institutes of Health

Career Start Year 1977

Number of shared co-authors 0

row(s) 1 - 30 of 30

Yoko Kosaka

Oregon Health & Science University

Co-authored papers 8

Shannon K McWeeney

Oregon Health & Science University, University of California Berkeley

Co-authored papers 6

Tak W Mak

Princess Margaret Cancer Centre, University Health Network

Co-authored papers 6

Brian J Druker

Oregon Health & Science University

Co-authored papers 5

Jeffrey W Tyner

Oregon Health & Science University School of Medicine

Co-authored papers 5

Adam J Lamble

Seattle Children's Hospital, University of Washington

Co-authored papers 5

Ted Laderas

Oregon Health & Science University

Co-authored papers 4

Andrew Wakeham

Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network

Co-authored papers 4

Nicola Long

Oregon Health and Science University

Co-authored papers 3

Motomi Mori

St Jude Children's Research Hospital.

Co-authored papers 3

Christopher A Eide

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Bill H Chang

Oregon Health and Science University

Co-authored papers 3

Marc M Loriaux

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Anupriya Agarwal

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Andy Kaempf

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 3

Jessica Leonard

Oregon Health & Science University

Co-authored papers 2

Daniel Bottomly

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Amy Carlos

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Beth Wilmot

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Robert H Collins

University of Texas Southwestern Medical Center

Co-authored papers 2

Rachel Henson

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Chenwei Lin

Clinical Research Division, Fred Hutchinson Cancer Center

Co-authored papers 2

Guanming Wu

Oregon Health and Science University

Co-authored papers 2

Amanda d'Almeida

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Cristina E Tognon

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Haijiao Zhang

Oregon Health & Science University, Knight Cancer Institute

Co-authored papers 2

Pierrette Lo

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Andrew J Elia

University Health Network, Princess Margaret Cancer Centre

Co-authored papers 2

David Tyler Sweeney

Knight Cancer Institute, Oregon Health & Science University

Co-authored papers 2

Guang Fan

Oregon Health and Science University

Co-authored papers 2

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators